199 related articles for article (PubMed ID: 24384873)
1. Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.
Huang RY; Li SS; Guo HZ; Huang Y; Zhang X; Li MY; Chen GG; Zeng X
J Cancer Res Clin Oncol; 2014 Mar; 140(3):375-86. PubMed ID: 24384873
[TBL] [Abstract][Full Text] [Related]
2. Testosterone treatment increases thromboxane function in rat cerebral arteries.
Gonzales RJ; Ghaffari AA; Duckles SP; Krause DN
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H578-85. PubMed ID: 15764681
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway.
Huang RY; Li MY; Ng CS; Wan IY; Kong AW; Du J; Long X; Underwood MJ; Mok TS; Chen GG
J Mol Cell Biol; 2013 Dec; 5(6):380-90. PubMed ID: 24115277
[TBL] [Abstract][Full Text] [Related]
5. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
6. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition.
Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA
J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil (Viagra®) Prevents Cox-1/ TXA2 Pathway-Mediated Vascular Hypercontractility in ApoE-/- Mice.
Leal MAS; Dias AT; Porto ML; Brun BF; Gava AL; Meyrelles SS; Gil-Longo J; Campos-Toimil M; Pereira TMC; Vasquez EC
Cell Physiol Biochem; 2017; 44(5):1796-1809. PubMed ID: 29216624
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080.
McNamara DB; Harrington JK; Bellan JA; Graybar GB; Underwood DC; Kadowitz PJ
Mol Cell Biochem; 1989 Jan; 85(1):29-41. PubMed ID: 2725478
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells.
Shiokoshi T; Ohsaki Y; Kawabe J; Fujino T; Kikuchi K
J Hypertens; 2002 Mar; 20(3):455-61. PubMed ID: 11875313
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 Synthase and Thromboxane Receptor Deletion Reduces Ischaemia/Reperfusion-Evoked Inflammation, Apoptosis, Autophagy and Pyroptosis.
Chueh TH; Cheng YH; Chen KH; Chien CT
Thromb Haemost; 2020 Feb; 120(2):329-343. PubMed ID: 31785598
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase.
Huang RY; Chu YL; Jiang ZB; Chen XM; Zhang X; Zeng X
Cell Physiol Biochem; 2014; 33(2):375-88. PubMed ID: 24556579
[TBL] [Abstract][Full Text] [Related]
12. 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.
Huang RY; Li MY; Hsin MK; Underwood MJ; Ma LT; Mok TS; Warner TD; Chen GG
Oncogene; 2011 Jan; 30(1):106-16. PubMed ID: 20818420
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
14. Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells.
Han J; Zhang L; Chen X; Yang B; Guo N; Fan Y
Exp Biol Med (Maywood); 2014 Mar; 239(3):272-83. PubMed ID: 24500985
[TBL] [Abstract][Full Text] [Related]
15. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
O'Keefe EH; Liu EC; Greenberg R; Ogletree ML
Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II constriction of rat vasa recta is partially thromboxane dependent.
Silldorff EP; Hilbun LR; Pallone TL
Hypertension; 2002 Oct; 40(4):541-6. PubMed ID: 12364360
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries.
Bolla M; You D; Loufrani L; Levy BI; Levy-Toledano S; Habib A; Henrion D
Hypertension; 2004 Jun; 43(6):1264-9. PubMed ID: 15096470
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500).
Masereel B; Damas J; Fontaine J; Lembege M; Lacan F; Nuhrich A; Delarge J; Pochet L; Dogne JM
J Pharm Pharmacol; 1999 Jun; 51(6):695-701. PubMed ID: 10454046
[TBL] [Abstract][Full Text] [Related]
19. Local anesthetic effects on TXA2 receptor mediated platelet aggregation using quenched flow aggregometry.
Honemann CW; Lo B; Erera JS; Polanowska-Grabowska R; Gear AR; Durieux M
Adv Exp Med Biol; 1999; 469():269-76. PubMed ID: 10667341
[No Abstract] [Full Text] [Related]
20. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
